Alyssa Pollizzi, Technology Insights
In October of 2012, we attended a meeting of the Radiological Devices Panel who provided the FDA with their recommendation for premarket approval of Hologic’s new C-View software.
This software is now FDA approved and has the ability to synthesize a 2D mammography image using information from the 3D tomosynthesis exposure on Hologic’s Selenia Dimensions unit.
A solution to the ‘double dose problem’ with tomosynthesis
Caitlin Visek, Technology Insights
After much speculation that the Centers for Medicare and Medicaid (CMS) was planning to implement a drastic cut in coverage of positron emission tomography (PET) scans, CMS released its surprising decision yesterday actually expanding coverage significantly.
PET wins big in landmark CMS ruling
Matthew Morrill, Technology Insights
Over the past year, many of our most progressive hospital members have asked us about an exciting new imaging technology—hybrid PET/MRI—with one major hesitation: reimbursement. As of June 11, 2013, there’s a lot less reason to worry.
A moment of clarity regarding PET/MRI reimbursement